Ortoma (ORT B) Stock Overview
Provides orthopedic surgical products for use in joint implant surgery in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
ORT B Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Ortoma AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 17.90 |
| 52 Week High | SEK 33.60 |
| 52 Week Low | SEK 6.90 |
| Beta | 0.74 |
| 1 Month Change | -22.84% |
| 3 Month Change | 44.94% |
| 1 Year Change | 99.78% |
| 3 Year Change | 5.92% |
| 5 Year Change | -46.41% |
| Change since IPO | 319.20% |
Recent News & Updates
Recent updates
Investors Will Want Ortoma's (STO:ORT B) Growth In ROCE To Persist
Oct 02
Ortoma (STO:ORT B) Might Have The Makings Of A Multi-Bagger
Jun 26Ortoma (STO:ORT B) Is In A Good Position To Deliver On Growth Plans
Mar 17Ortoma (STO:ORT B) Is In A Strong Position To Grow Its Business
Nov 13Ortoma (STO:ORT B) Is In A Strong Position To Grow Its Business
Oct 25Ortoma (STO:ORT B) Is Doing The Right Things To Multiply Its Share Price
Sep 20We're Keeping An Eye On Ortoma's (STO:ORT B) Cash Burn Rate
Jun 03We Think Ortoma (NGM:ORT B) Can Afford To Drive Business Growth
Dec 09Ortoma (NGM:ORT B) Is In A Good Position To Deliver On Growth Plans
Aug 17Shareholder Returns
| ORT B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -12.3% | 1.4% | 2.7% |
| 1Y | 99.8% | -19.2% | -1.2% |
Return vs Industry: ORT B exceeded the Swedish Medical Equipment industry which returned -19.9% over the past year.
Return vs Market: ORT B exceeded the Swedish Market which returned -1.7% over the past year.
Price Volatility
| ORT B volatility | |
|---|---|
| ORT B Average Weekly Movement | 17.7% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in SE Market | 12.1% |
| 10% least volatile stocks in SE Market | 3.0% |
Stable Share Price: ORT B's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: ORT B's weekly volatility has increased from 12% to 18% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 10 | Fredrik Stromberg | www.ortoma.com |
Ortoma AB (publ) provides orthopedic surgical products for use in joint implant surgery in Sweden. It offers Ortoma Treatment Solution (OTS) that is designed to support various orthopedic joint or spine surgeries in the areas of hip, spine, knee, and shoulders and extremities surgeries; OTS Plan, a software that processes and assists surgeons during pre-operative planning and post-operative follow-up; OTS Guide, an intra-operative navigation tool guiding surgeons to place the implant in the pre-operatively planned position; and OTS Follow up that is used as support in the postoperative follow-up of a patient through a low-dose computed tomography of the joint. The company was incorporated in 2001 and is based in Gothenburg, Sweden.
Ortoma AB (publ) Fundamentals Summary
| ORT B fundamental statistics | |
|---|---|
| Market cap | SEK 663.80m |
| Earnings (TTM) | SEK 6.11m |
| Revenue (TTM) | SEK 90.09m |
Is ORT B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ORT B income statement (TTM) | |
|---|---|
| Revenue | SEK 90.09m |
| Cost of Revenue | SEK 45.83m |
| Gross Profit | SEK 44.26m |
| Other Expenses | SEK 38.14m |
| Earnings | SEK 6.11m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 49.13% |
| Net Profit Margin | 6.79% |
| Debt/Equity Ratio | 0% |
How did ORT B perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/03 03:31 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ortoma AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Klas Palin | DNB Carnegie Commissioned Research |
| Mats Hyttinge | Redeye |